Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Net income	$ 13,957	$ 275,451
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	19,381	11,862
Net (gains) losses realized on the sale of securities and net credit losses recognized in operations	35,898	(198,310)
Unrealized (gains) losses on equity securities	(96,321)	(246,126)
Change in fair value of embedded derivative	(79,929)	97,334
(Accretion) amortization of investment securities, net	(112,213)	(127,339)
Deferred acquisition costs capitalized	(124,726)	(131,820)
Deferred acquisition costs amortized	362,810	367,122
Value of business acquired amortized	23,105	23,105
Interest credited on deposit type contracts	454,517	431,983
(Increase) decrease in operating assets:
Investment income due and accrued	(159,459)	(102,904)
Reinsurance related assets	417,581	(165,228)
Other assets	41,104	13,729
Increase (decrease) in operating liabilities:
Policyowner benefit reserves	1,145,795	1,052,734
Dividend accumulation	919	975
Advance premiums	19,340	(3,583)
Other liabilities	144,098	35,839
Accounts payable and accrued expenses	279,586	927,004
Net cash provided by operating activities	2,385,443	2,261,828
Cash Flows from investing activities:
Purchase of fixed income investments	(2,507,233)	(1,088,214)
Purchase of equity investments	(101,406)	(1,308)
Purchase of mortgage investments	(252,642)	(1,673,256)
Purchase of other invested assets	(26,320)	(120,091)
Proceeds from fixed income sales and repayments	2,277,763	1,689,780
Proceeds from equity sales	96,428	44,835
Proceeds from mortgage repayments	1,200,925	1,503
Proceeds from other invested assets	5,440	0
Increase in policy loans	(623)	(767)
Purchase of property, equipment and software	(11,127)	(36,353)
Net cash provided by (used in) investing activities	681,205	(1,183,871)
Cash Flows from financing activities:
Receipts on deposit-type contracts	2,119,530	1,518,509
Withdrawals on deposit-type contracts	(3,024,646)	(2,643,963)
Net cash used in financing activities	(905,116)	(1,125,454)
Net increase (decrease) in cash and cash equivalents	2,161,532	(47,497)
Cash and Cash Equivalents:
Beginning	8,982,138	4,091,507
Ending	$ 11,143,670	$ 4,044,010